Get the app!
Back to Trades
Other3

Evommune, Inc.

EVMN

Total Value
$NaN

Company Information

Company Name
Evommune, Inc.
Ticker Symbol
EVMN
CIK
0002044725

Insider Information

Role
Insider
Location
PALO ALTO, CA

Filing Details

Filing Date
Nov 5, 2025
Transaction Date
Nov 5, 2025
Accession Number
0002092017-25-000003
Form Type
3

Footnotes

  1. (F1)These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. One fourth (1/4) of the RSUs shall vest on each of December 9, 2025, December 9, 2026, December 9, 2027 and December 9, 2028, subject to the Reporting Person's continuous service through each such vesting date.
  2. (F2)The Series B Preferred Stock is convertible into Common Stock on a 1-for-7.8721 basis and has no expiration date. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock will be converted into shares of Common Stock of the Issuer.
  3. (F3)One fourth (1/4) of the shares subject to the option award vested on October 3, 2023 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  4. (F4)One fourth (1/4) of the shares subject to the option award vested on January 13, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  5. (F5)One fourth (1/4) of the shares subject to the option award vested on May 12, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  6. (F6)One fourth (1/4) of the shares subject to the option award vested on December 11, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  7. (F7)One fourth (1/4) of the shares subject to the option award shall vest on December 9, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.